Luminist Labs

Acquired

Diagnostic platform for early detection of liver disease

Winter 2016Founded 20152 peopleNewark, CA, USA

↻ Pivot / rename signal

This company has previously operated under “Luminist”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.

About

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.